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A key feature of early mammalian embryo development is
the presence of two distinct phases, pre- and post-implanta-
tion – also called embryogenic and embryonic (Johnson and
Selwood, 1996). The first phase leads to the separation of
two types of tissue: the epiblast, from which the future
body of the embryo will be built, and the tropho- and hypo-ter ª 2013, Reproductive Healthcare Ltd.
.rbmo.2013.02.009blast, from which extra-embryonic tissues derive to provide
support for development in the uterus. The second phase
centres on differentiation within both types of tissue, nota-
bly the emergence of embryonic cells from the epiblast that
leads to formation of the three embryonic germ layers that
will form the structures and organs of the embryo and then
the fetus (Arnold and Robertson, 2009; Beddington, 1983;
Beddington and Robertson, 1999; Gardner, 1978; Hayashi
et al., 2007; Rossant, 1984; Weber et al., 1999).Published by Elsevier Ltd. All rights reserved.
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tation phase has been increased significantly (Johnson,
2009; Rossant and Tam, 2009; Zernicka-Goetz et al., 2009).
In particular, considerable knowledge has been gained
recently from following cell behaviour in real time using
time-lapse video microscopy (Bischoff et al., 2008; Cock-
burn and Rossant, 2010; Grabarek et al., 2012; Jedrusik
et al., 2008, 2010; Kurotaki et al., 2007; Morris et al., 2010;
Plusa et al., 2005, 2008; Rossant and Tam, 2009; Sasaki,
2010; Zernicka-Goetz et al., 2009). Even though there are
comprehensive studies on cell movements and rearrange-
ments in the post-implantation embryo (Joyce and Srinivas,
2012; Takaoka and Hamada, 2012; Trichas et al., 2012), the
detailed description of implantation and processes accom-
panying transition of the preimplantation blastocyst into
the post-implantation embryo are still missing. The major
obstacle limiting the ability to achieve greater understand-
ing of the dynamics of this transition is the process of
implantation and the further dependence of embryo wellbe-
ing on maternal support. Despite several reports of
attempts to culture embryos continuously throughout the
pre- and post-implantation phases (Hsu, 1973, 1979; Huang
et al., 2001; Konwinski et al., 1978; Libbus and Hsu, 1980;
Pienkowski et al., 1974; Tournaye et al., 1993; Wiley
et al., 1978), they have not been widely adopted in the
study of mammalian embryology. One reason for this may
have been the inability to combine these culture approaches
with time-lapse video microscopy, which limited the
dynamic picture of developmental processes attained and
so did not provide much new information in comparison with
static pictures resulting from analysing embryos recovered
at successive stages following implantation.
Recently, the Cambridge group led by Magdalena
Zernicka-Goetz reported the development of a novel
in-vitro culture system that allows the transition between
pre- and post-implantation phases in the mouse embryo to
be followed in real time through the egg cylinder stage as
far as the onset of gastrulation (Morris et al., 2012). In this
system, embryos develop on the surface of glass bottom
dishes coated with hydrogel and a layer of extracellular
matrix proteins. Importantly, application of imaging com-
patible dishes enabled this method to combine culture with
time-lapse confocal microscopy, thereby providing insight
into early embryonic processes at the level of cellular reso-
lution. This approach allowed the Cambridge group to pro-
vide a precise description of anterior visceral endoderm
development, a tissue essential for establishment of the
first axis of polarity in the post-implantation embryo (Morris
et al., 2012). Importantly, the study showed that embryos
grown in this in-vitro system are morphologically and molec-
ularly equivalent to embryos grown within the mouse uterus
(Figure 1) (Morris et al., 2012). Thus, both show appropri-
ate spatiotemporal expression patterns of key anterior and
posterior marker genes such as Cerl, Lefty1 or Brachyury,
indicating that a proper organization of tissues is occurring
within the ‘post-implantation’ in-vitro embryo. In addition,
embryonic stem cells, aggregated with mouse preimplanta-
tion embryos, became incorporated into the appropriate tis-
sues of the egg cylinder. Together, these observations
indicate that this novel culture system provides an ideal
platform for detailed investigation of the mechanisms gov-
erning early morphogenesis.The new culture system and understanding
early morphogenesis
There are many processes in early post-implantation devel-
opment that are not fully understood and would benefit
from a comprehensive description at the cellular and molec-
ular levels. One advantage of the new culture system is the
ease with which it can utilize available transgenic mouse
lines, such as those in which particular cellular components,
such as chromatin or cell membranes, are labelled (Hadjan-
tonakis and Papaioannou, 2004; Rhee et al., 2006; Shioi
et al., 2011). Thus, use of endogenous vital labels allows
characterization of dynamic processes to provide accurate
and detailed pictures of development. For example, the
ability to trace cellular components in live pre-implantation
embryos has provided comprehensive databases on cell
positions, shapes, division patterns and migratory tracks.
These data have allowed a quantitative assessment to be
made of the relative significance of lineage and microenvi-
ronment (or position) to a cell’s developmental fate and
have proved invaluable for understanding preimplantation
events (Figure 2) (Bischoff et al., 2008; Cockburn and Ros-
sant, 2010; Grabarek et al., 2012; Jedrusik et al., 2008,
2010; Kurotaki et al., 2007; Morris et al., 2010; Plusa
et al., 2005, 2008; Rossant and Tam, 2009; Sasaki, 2010;
Zernicka-Goetz et al., 2009). The new in-vitro culture plat-
form could deliver a similar understanding for the peri- and
post-implantation phases, facilitating the construction of
morphogenetic blueprints for particular tissues and struc-
tures. In addition to the characterization of normal develop-
ment, the culture system also enables the observation in
real time of the development of mutant or experimentally
manipulated embryos by measuring such cell-level behav-
iours as mitosis, cell polarity and lineage mapping during
complex tissue movements.
Understanding development that fails to form tissues or
structures correctly in the context of an embryo aids iden-
tification of key transcription factors, signalling molecules
or other proteins that are required for advancement from
one stage to the next. The dynamic character of these stud-
ies is likely to uncover novel components of the organiza-
tional blueprints for the subsequent patterning of the
fetal body. Such studies assume particular significance for
developmental events that span the period of implantation.
Thus, Morris et al. (2012) not only described how the ante-
rior visceral endoderm forms after implantation but also
traced back the precursors of this lineage into the blasto-
cyst stage. This example shows that continuity of observa-
tions across pre- and post-implantation phases allows
discovery of associations that would otherwise be difficult
to identify. The ability to link pre- and post-implantation
events is invaluable.Study of environmental impacts on
development
In recent years, an increasing number of studies has shown
that the environment at the time of conception and during
early preimplantation development can have a direct
impact on the health of the fetus and adult organism
Figure 1 Schematic representation of mouse egg cylinder developed in vitro (left panel) and in vivo (right panel). In-vitro embryos
developed on glass bottom dishes with hydrogel bonded to the glass and overlaid with layer of extracellular matrix (ECM) proteins.
In-vitro and in-vivo egg cylinders are morphologically similar and consist of distinct embryonic and extra-embryonic parts. They both
have a well-developed pro-amniotic cavity and a similar expression pattern of marker genes critical for anterior–posterior axis
formation such as Cerl and Lefty (green, anterior marker) or Brachyury (red, posterior marker). The epiblast that will form the
future body of the fetus is shown in yellow. (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
Figure 2 Lineage tracing technology has proved essential for understanding preimplantation development. Following cell
behaviour by tracing in real time the positions of cell structures such as the nucleus allows the construction of lineage trees which
incorporate both the history and fate of individual cells within the embryo. In the example shown here, clones of each cell from a
2-cell-stage embryo are shown in either red or dark blue. As progeny of these clones acquires an inside position, their colours change
to yellow and light blue, respectively. Inside cells are progenitors of the epiblast, which will build the body of the fetus, and the
hypoblast, which will form the yolk sac; outside cells differentiate into trophectoderm that will give rise to placenta. During normal
development, lineages originate in comparable proportions from both clones (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.).
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558 A Jedrusik(Fleming et al., 2012; Warner and Ozanne, 2010; Watkins
and Fleming, 2009). In a range of animal models, it was
demonstrated thatmanipulation of the preimplantation envi-
ronment in vivo (diet) or in vitro (culture conditions) can
adversely affect the post-natal phenotype (Fleming et al.,
2004; Sinclair et al., 2007; Watkins and Fleming, 2009;
Watkins et al., 2008). For example, a nutrient-restricted diet
during the mouse pre-implantation period was shown to alter
embryo metabolism (Mitchell et al., 2009) and affect cell
allocation to blastocyst lineages (Kwong et al., 2000; Mitchell
et al., 2009). Astonishingly, it also resulted in an increased
incidence of cardiovascular disease in adult mice, even when
exposure to such diet was applied exclusively during early
pre-implantation stages (Watkins et al., 2008). This finding
suggests the existence of early ‘sensing’ mechanisms within
the embryo that adaptively optimize fetal growth and
post-natal fitness to anticipated environmental conditions.
The mechanism by which this adaptation occurs is not yet
understood. However, the novel in-vitro culture platform
could prove useful in shedding more light on the mechanisms
underlying this phenomenon.
The potential of the novel culture system for
regenerative medicine
Recently, much hope and attention has been given to the
potential use of pluripotent cells in regenerative medicine
(Blanpain et al., 2012; Cohen and Melton, 2011; Lo´pez-Gon-
za´lez and Velasco, 2012; Pfannkuche et al., 2010; Robinton
and Daley, 2012; Shi, 2009; Unternaehrer and Daley, 2011).
Many human diseases, such as neurodegenerative disorders,
diabetes and certain types of liver and heart failure, are
caused by defects in the quantity or functionality of partic-
ular cell types. Pluripotent cells, including embryonic stem
cells and induced pluripotent stem cells are noted for their
ability to become converted to cells with a particular fate,
and as such seem to be suitable for use in cell replacement
therapies. However, the ability to control the process of
acquiring a particularly desired cell fate is limited. It has
been estimated that, even for highly optimized protocols,
the efficiency of differentiation/reprogramming to a pre-
ferred tissue type does not exceed 30% (Cohen and Melton,
2011). In order to be able to use pluripotent cells in human
medical treatments this efficiency has to increase dramati-
cally. One way to achieve that increase is to gain more
understanding about how a particular cell type is produced
during early morphogenesis. As discussed above, this goal
should be greatly facilitated by use of the novel culture
platform. However, there is one important aspect that can-
not be overlooked. Most of the knowledge and protocols
relating to pluripotent cells were established in mouse,
and between-species differences are becoming evident
(Cohen and Melton, 2011; De Los Angeles et al., 2012; Nic-
hols and Smith, 2009; Rossant, 2011). For example, in strik-
ing contrast to what is observed for mouse, primate
embryonic stem cells make poor contributions to full devel-
opment after their injection into a host embryo (James
et al., 2006; Simerly et al., 2011; Tachibana et al., 2012),
which suggest that they are not as pluripotent as their
mouse counterparts. Given the medical potential of primate
embryonic stem cells, it is crucial to understand howpluripotent these cells really are and to what extent their
fate can be modulated. Study of these cells in the new cul-
ture system with respect to lineage commitment and
within-embryo cell interactions, could form an initial but
critical step towards progress in regenerative medicine.
Cell replacement therapy is not the only area of interest
in regenerative medicine. An additional important aspect is
the production of organs for transplantation. We live in era
desperate for ethically acceptable and safe sources of
human organs (Epstein, 2009; Khamash and Gaston, 2008;
Steering Committee of the Istanbul Summit, 2008).
Recently, significant progress has been made in production
of functional organs in vivo. Using rodents as model organ-
isms, researchers were able to ‘produce’ pancreas (Kobay-
ashi et al., 2010), kidney (Usui et al., 2012) and thymus
(Isotani et al., 2011) via a ‘blastocyst complementation’
technique in which pluripotent cells were introduced into
an embryo that was incapable itself of producing certain tis-
sue types or organs (Chen et al., 1993). In this way, the
empty developmental niche provided by the mutant embryo
could be populated by pluripotent cells and the missing
organ or tissue successfully produced. One can imagine that
a similar system could be applied in the clinic, though
human organs would have to be produced in xenogeneic sys-
tems, such as chimeric pigs or other large animals (Kobay-
ashi et al., 2010). However, achieving viable interspecific
chimeras has proved to be difficult. Even in the best-studied
rodent species, full-term development of rat–mice chime-
ras is very low, with a high contribution of xenogeneic cells
being associated with morphological abnormalities and
embryonic lethality (Benin et al., 1997; Gardner and John-
son, 1973; Kobayashi et al., 2010; Usui et al., 2012). The
nature of this xenogeneic barrier is unclear. Thus, under-
standing early morphogenesis with the aid of the novel cul-
ture platform may clarify this issue by identifying
mechanisms responsible for failed development and in turn,
help to establish future reliable organ ‘factories’.
In-vitro culture system and developmental
toxicology
Finally, an in-vitro culture platform can aid assessment of
safety of drugs and other chemicals for normal fetal devel-
opment during pregnancy. Currently, developmental toxic-
ity testing is based on traditional animal studies where the
risk to prenatal development is assessed based on high-dos-
age oral administration of the test substance at distinct
stages of pregnancy (Knudsen et al., 2011; Webster et al.,
1997). This method of assessment is costly and low-through-
put, and the adverse embryonic outcome is difficult to
translate into a particular concentration of chemical com-
pound (Hartung, 2009). As a result, the data on develop-
mental effects is available for only a small fraction of
chemicals in broad use worldwide (Knudsen et al., 2011).
Screening developmental toxicity in vitro should greatly
improve this situation. Additional to economic benefits, an
in-vitro system should expand the range of data obtained
from toxicological assessments. For example, by compari-
son with the substantial body of data acquired from in-vitro
culture of control embryos, it should not only be possible to
estimate the toxic dosage range of the tested chemical, but
A novel in-vitro culture platform 559should also facilitate understanding of the cellular mecha-
nisms involved in developmental toxicity. The tracking of
movements and history of individual cells in the growing
embryo that is facilitated by this in-vitro platform will allow
assessment of early biological consequences of exposure to
the chemical compound and hopefully will facilitate devel-
opment of preventive strategies to avoid adverse morpho-
logical phenotypes.Conclusion
In summary, the novel in-vitro culture platform provides a
powerful tool to study early morphogenesis and understand
processes underlying normal as well as abnormal develop-
ment. As presented above, this system promises to eluci-
date the consequences for embryonic cells and
therapeutically potent pluripotent cells of complex aspects
of lineage commitment and interactions. It should be noted
that this approach is not free from challenges especially,
when considering its implementation for human
embryos/tissues. From a technical point of view, this sys-
tem was developed using mouse embryos and it will be nec-
essary to adapt and optimize it to support human tissue
development. Also, ‘implanting’ human embryos in vitro
can lead to ethical and legal concerns such as the issues
of to when legally the human embryo can be cultured and
what procedures can ethically and legally be performed on
them in different jurisdictions. These are matters for wide
debate across the whole of society. Notwithstanding, imple-
mentation of this in-vitro system has the potential to
uncover mechanisms that underlie early morphogenesis,
which in turn could have a direct impact on human health.Acknowledgement
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